Harris Associates
LLY icon

Harris Associates’s Eli Lilly LLY Stock Holding History

Harris Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Sell
431
-19
-4% -$19.4K ﹤0.01% 133
2026
Q1 		$414K Buy
450
+36
+9% +$36.5K ﹤0.01% 137
2025
Q4 		$445K Hold
414
– – ﹤0.01% 139
2025
Q3 		$316K Hold
414
– – ﹤0.01% 139
2025
Q2 		$323K Buy
+414
New +$322K ﹤0.01% 141
2015
Q2 		– Sell
-3,100
Closed -$225K – 151
2015
Q1 		$225K Sell
3,100
-710
-19% -$50.5K ﹤0.01% 164
2014
Q4 		$263K Buy
3,810
+110
+3% +$7.42K ﹤0.01% 173
2014
Q3 		$240K Hold
3,700
– – ﹤0.01% 169
2014
Q2 		$230K Hold
3,700
– – ﹤0.01% 175
2014
Q1 		$218K Buy
+3,700
New +$206K ﹤0.01% 176

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harris Associates's LLY Position: Q2 2026 in Review

Harris Associates reduced its Eli Lilly (LLY) stake by 4.2% in Q2 2026, selling an estimated $19.4K and leaving 431 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #133.

Harris Associates first reported a position in LLY in Q1 2014 and has held it in 10 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harris Associates held 431 shares of Eli Lilly worth $517K as of Q2 2026.
  • Harris Associates sold 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up ﹤0.01% of Harris Associates's portfolio in Q2 2026, its #133 holding.
  • Harris Associates first reported a position in Eli Lilly in Q1 2014 and has held it in 10 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harris Associates's 13F filing for Q2 2026, filed 14 Aug 2026.